Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2026-01-06 @ 7:21 AM
Study NCT ID:
NCT00458367
Status:
COMPLETED
Last Update Posted:
2010-10-18
First Post:
2007-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
Sponsor:
Janssen Pharmaceutica N.V., Belgium
Organization:
Conditions & Keywords Data
Conditions: